Translating ESC/EAS Dyslipidemia Guidelines to clinical practice
Which is/are determinant(s) of LDL-c-associated CV risk?
- A. time to reach LDL-c target goal
- B. duration at LDL-c target goal
- C. approaches of reaching LDL-c target goal (statin, ezetimibe or PCSK9i)
- D. A and B are true
- E. A, B and C are true
This educational video is part of a series aimed to shed light on what is now established on LDL-c and the risks it confers, and how we can best manage elevated LDL-c levels and why.
Prof. Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
This educational series is funded by an unrestricted educational grant provided by Amgen. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: